MetaStat Inc MTST:OTC Pink - No Information

Last Price$0.0208NASDAQ Previous Close - as of 12:38PM ET 9/21/20

Today's Change0.00(0.00%)
Bid (Size)$0.0072 (10,000)
Ask (Size)$0.09 (10,000)
Day Low / High$0.0208 - 0.0208
Volume1.0 K

Read more news Recent News

No news stories available at this time.

View all Commentary and Analysis

No news stories available at this time.

Company Profile

Business DescriptionMetaStat, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes MetaSite Breast and MenaCalc platforms. The MetaSite Breast test measures the process of systemic metastasis and is intended for early stage breast cancer patients. The MenaCalc, a platform of diagnostic assays, based on the measurement of the balance of the Mena protein isoforms, is broadly applicable in solid epithelial-based cancers, including breast, prostate, lung and colorectal. The company was founded by Warren C. Lau in July 2009 and is headquartered in Boston, MA. View company web site for more details
Address27 Drydock Avenue
Boston, Massachusetts 02210-2377
Number of Employees6
President, Chief Executive Officer, CFO & DirectorDouglas A. Hamilton
Chief Medical OfficerMichael J. Donovan
Vice President-Investor & Media RelationsFrederick E. Pierce

Company Highlights

Price Open$0.02
Previous Close$0.02
52 Week Range$0.0023 - 0.04
Market Capitalization$121.9 K
Shares Outstanding5.9 M
SectorProducer Manufacturing
IndustryElectrical Products
Next Earnings AnnouncementN/A

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.67
Beta vs. S&P 500N/A
Revenue$23.3 K
Net Profit Margin-13,652.46%
Return on Equity340.32%

Analyst Ratings as of 10/05/2015

Consensus RecommendationConsensus Icon
Powered by Factset